Gennex Laboratories [GENNEX] vs Divi's Laboratories [DIVISLAB] Detailed Stock Comparison
Gennex Laboratories
BSE
Loading...
Divi's Laboratories
NSE
Loading...
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Gennex Laboratories wins in 6 metrics, Divi's Laboratories wins in 13 metrics, with 0 ties. Divi's Laboratories appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Gennex Laboratories | Divi's Laboratories | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 15.87 | 70.40 | Gennex Laboratories |
| Price-to-Book Ratio | 1.14 | 10.87 | Gennex Laboratories |
| Debt-to-Equity Ratio | 13.93 | 0.03 | Divi's Laboratories |
| PEG Ratio | 0.81 | 108.91 | Gennex Laboratories |
| EV/EBITDA | 11.60 | 51.98 | Gennex Laboratories |
| Profit Margin (TTM) | 11.69% | 23.89% | Divi's Laboratories |
| Operating Margin (TTM) | 3.65% | 25.60% | Divi's Laboratories |
| EBITDA Margin (TTM) | 3.65% | 25.60% | Divi's Laboratories |
| Return on Equity | 9.77% | 14.64% | Divi's Laboratories |
| Return on Assets (TTM) | 3.79% | 12.94% | Divi's Laboratories |
| Free Cash Flow (TTM) | $-197.44M | $2.15B | Divi's Laboratories |
| Dividend Yield | N/A | 0.91% | N/A |
| 1-Year Return | -12.64% | 22.45% | Divi's Laboratories |
| Price-to-Sales Ratio (TTM) | 2.18 | 16.86 | Gennex Laboratories |
| Enterprise Value | $1.94B | $1,593.02B | Divi's Laboratories |
| EV/Revenue Ratio | 1.41 | 16.51 | Gennex Laboratories |
| Gross Profit Margin (TTM) | 19.91% | 60.33% | Divi's Laboratories |
| Revenue per Share (TTM) | $7 | $363 | Divi's Laboratories |
| Earnings per Share (Diluted) | $0.78 | $87.10 | Divi's Laboratories |
| Beta (Stock Volatility) | 0.42 | 0.27 | Divi's Laboratories |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Gennex Laboratories vs Divi's Laboratories Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Gennex Laboratories | -0.65% | -2.30% | -3.91% | -2.15% | -11.06% | -28.24% |
| Divi's Laboratories | -3.54% | -7.03% | -14.75% | -0.77% | -0.41% | -2.61% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Gennex Laboratories | -12.64% | 87.21% | 204.46% | 345.65% | 668.75% | 884.00% |
| Divi's Laboratories | 22.45% | 58.73% | 91.42% | 441.88% | 1,482.26% | 9,037.19% |
Performance & Financial Health Analysis: Gennex Laboratories vs Divi's Laboratories
| Metric | GENNEX | DIVISLAB |
|---|---|---|
| Market Information | ||
| Market Cap | ₹3.01B | ₹1.63T |
| Market Cap Category | Small cap | Large cap |
| 10 Day Avg. Volume | 359,720 | 416,189 |
| 90 Day Avg. Volume | 540,131 | 360,518 |
| Last Close | ₹12.30 | ₹5,914.50 |
| 52 Week Range | ₹11.15 - ₹29.00 | ₹4,615.55 - ₹7,071.50 |
| % from 52W High | -57.59% | -16.36% |
| All-Time High | ₹29.00 (Sep 16, 2024) | ₹7,071.50 (Jul 08, 2025) |
| % from All-Time High | -57.59% | -16.36% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.20% | 0.14% |
| Quarterly Earnings Growth | -0.48% | 0.27% |
| Financial Health | ||
| Profit Margin (TTM) | 0.12% | 0.24% |
| Operating Margin (TTM) | 0.04% | 0.26% |
| Return on Equity (TTM) | 0.10% | 0.15% |
| Debt to Equity (MRQ) | 13.93 | 0.03 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | ₹10.85 | ₹563.87 |
| Cash per Share (MRQ) | ₹3.23 | ₹132.86 |
| Operating Cash Flow (TTM) | ₹-107,970,000 | ₹19.67B |
| Levered Free Cash Flow (TTM) | ₹-242,337,744 | ₹21.91B |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | 0.91% |
| Last 12-Month Dividend | ₹0.00 | ₹60.00 |
Valuation & Enterprise Metrics Analysis: Gennex Laboratories vs Divi's Laboratories
| Metric | GENNEX | DIVISLAB |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 15.87 | 70.40 |
| Forward P/E | N/A | 108.91 |
| PEG Ratio | 0.81 | 108.91 |
| Price to Sales (TTM) | 2.18 | 16.86 |
| Price to Book (MRQ) | 1.14 | 10.87 |
| Market Capitalization | ||
| Market Capitalization | ₹3.01B | ₹1.63T |
| Enterprise Value | ₹1.94B | ₹1.59T |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 1.41 | 16.51 |
| Enterprise to EBITDA | 11.60 | 51.98 |
| Risk & Other Metrics | ||
| Beta | 0.42 | 0.27 |
| Book Value per Share (MRQ) | ₹10.85 | ₹563.87 |
Financial Statements Comparison: Gennex Laboratories vs Divi's Laboratories
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | GENNEX | DIVISLAB |
|---|---|---|
| Revenue/Sales | ₹403.25M | ₹24.10B |
| Cost of Goods Sold | ₹322.95M | ₹9.56B |
| Gross Profit | ₹80.30M | ₹14.54B |
| Research & Development | N/A | N/A |
| Operating Income (EBIT) | ₹-51.25M | ₹6.17B |
| EBITDA | ₹58.48M | ₹8.48B |
| Pre-Tax Income | ₹41.05M | ₹7.33B |
| Income Tax | ₹10.75M | ₹1.88B |
| Net Income (Profit) | ₹30.30M | ₹5.45B |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | GENNEX | DIVISLAB |
|---|---|---|
| Cash & Equivalents | ₹5.53M | ₹4.15B |
| Total Current Assets | ₹1.81B | ₹100.81B |
| Total Current Liabilities | ₹445.53M | ₹14.52B |
| Long-Term Debt | ₹0 | ₹20.00M |
| Total Shareholders Equity | ₹1.95B | ₹149.69B |
| Retained Earnings | N/A | ₹134.00B |
| Property, Plant & Equipment | ₹566.08M | ₹3.19B |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | GENNEX | DIVISLAB |
|---|---|---|
| Operating Cash Flow | N/A | N/A |
| Capital Expenditures | N/A | N/A |
| Free Cash Flow | N/A | N/A |
| Debt Repayment | N/A | N/A |
| Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | GENNEX | DIVISLAB |
|---|---|---|
| Shares Short | N/A | N/A |
| Short Ratio | N/A | N/A |
| Short % of Float | N/A | N/A |
| Average Daily Volume (10 Day) | 359,720 | 416,189 |
| Average Daily Volume (90 Day) | 540,131 | 360,518 |
| Shares Outstanding | 227.45M | 265.47M |
| Float Shares | 92.23M | 120.74M |
| % Held by Insiders | 0.31% | 0.52% |
| % Held by Institutions | 0.00% | 0.29% |
Dividend Analysis & Yield Comparison: Gennex Laboratories vs Divi's Laboratories
| Metric | GENNEX | DIVISLAB |
|---|---|---|
| Last 12-Month Dividend | ₹0.00 | ₹60.00 |
| Last 12-Month Dividend Yield | N/A | 0.91% |
| 3-Year Avg Annual Dividend | ₹0.00 | ₹50.00 |
| 3-Year Avg Dividend Yield | N/A | 0.70% |
| 3-Year Total Dividends | ₹0.00 | ₹150.00 |
| Ex-Dividend Date | N/A | Jul 25, 2025 |